Income Statement

ARDENT HEALTH, INC.

ARDT
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY
Revenue
6,324.34 5,966.07
Cost of Revenue
- -
Gross Profit
6,324.34 5,966.07
Operating Expenses
0.00 0.00
Research & Development
- -
Selling, General & Administrative
2,657.70 2,534.76
Other Operating Expenses
- -
Operating Income
6,324.34 5,966.07
Non-Operating Income
6,023.34 5,603.01
Interest Income
- -
Interest Expense
55.20 65.58
Other Non-Op Income / Expense
- -
Income Before Tax
301.00 363.06
Income Tax Expense
165.19 152.72
Non-Controlling Interest
94.32 89.37
Net Income
135.81 210.34
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY
Depreciation & Amortization
- -
EBITDA
6,480.04 6,112.37
Earnings Per Share (Basic)
0.96 1.59
Diluted EPS
0.96 1.58
Weighted Average Shares
140.76 132.44
Diluted Weighted Avg Shares
141.45 132.74
Comprehensive Income
122.46 201.52